Ethyl (2E)-2-(hydroxyimino)-3-oxobutanoate

CAS: 5408-04-8

Ref. 3D-FE118909

Información del producto

• Nombre: Ethyl (2E)-2-(hydroxyimino)-3-oxobutanoate
• Sinónimos: 2-(Hydroxyimino)-3-oxobutyric acid ethyl ester, 2-Hydroxyimino-3-oxobutanoic acid ethyl ester, Butanoic Acid, 2-(Hydroxyimino)-3-Oxo-, Ethyl Ester, Butanoic acid, 2-(hydroximino)-3-oxo-, ethyl ester, Butyric acid, 2,3-dioxo-, ethyl ester, 2-oxime, Butyric acid, α,β-dioxo-, ethyl ester α-oxime, Ethyl 2-(Hydroxyimino)-3-Oxobutanoate, Ethyl 2-(hydroxyimino)-3-ketobutyrate, Ethyl 2-(hydroxyimino)acetoacetate, Ethyl 2-oximinoacetoacetate, Ethyl α-(hydroxyimino)acetoacetate, Ethyl α-isonitrosoacetoacetate, Ethyl α-oximinoacetoacetate, NSC 10758, butanoic acid, 2-(hydroxyimino)-3-oxo-, ethyl ester, (2E)-
• CAS: 5408-04-8

Descripción

Ethyl 2-hydroxyimino-3-oxobutanoate (EHIO) is a chromatographic method for the separation of hydrochloric acid and its derivatives. It is also used as an antiplatelet drug in clinical use. EHIO has molecular weight of 176.2 g/mol and has been shown to have antiplatelet effects, which may be due to its ability to inhibit serine proteases such as thrombin, factor Xa, and factor XIIa. EHIO binds to the active site of these enzymes by competitive inhibition and prevents them from catalyzing reactions that would result in the formation of thrombin, a key step in the coagulation cascade. Ticagrelor is an antiplatelet medication that inhibits P2Y12 receptors on platelets through competitive inhibition with ADP or other nucleotides. This binding prevents ADP from binding to P2Y12 receptors and inhibiting adenylate cycl

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 159.14 g/mol
• Fórmula: C₆H₉NO₄
• Pureza: Min. 95%